Literature DB >> 30397337

A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data.

Benjamin J Ainscough1,2, Erica K Barnell1, Peter Ronning1, Katie M Campbell1, Alex H Wagner1, Todd A Fehniger2,3, Gavin P Dunn4, Ravindra Uppaluri5, Ramaswamy Govindan2,3, Thomas E Rohan6, Malachi Griffith1,2,3,7, Elaine R Mardis8,9, S Joshua Swamidass10,11, Obi L Griffith12,13,14,15.   

Abstract

Cancer genomic analysis requires accurate identification of somatic variants in sequencing data. Manual review to refine somatic variant calls is required as a final step after automated processing. However, manual variant refinement is time-consuming, costly, poorly standardized, and non-reproducible. Here, we systematized and standardized somatic variant refinement using a machine learning approach. The final model incorporates 41,000 variants from 440 sequencing cases. This model accurately recapitulated manual refinement labels for three independent testing sets (13,579 variants) and accurately predicted somatic variants confirmed by orthogonal validation sequencing data (212,158 variants). The model improves on manual somatic refinement by reducing bias on calls otherwise subject to high inter-reviewer variability.

Entities:  

Mesh:

Year:  2018        PMID: 30397337      PMCID: PMC6428590          DOI: 10.1038/s41588-018-0257-y

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  17 in total

1.  Semi-supervised learning for somatic variant calling and peptide identification in personalized cancer immunotherapy.

Authors:  Elham Sherafat; Jordan Force; Ion I Măndoiu
Journal:  BMC Bioinformatics       Date:  2020-12-30       Impact factor: 3.169

2.  Automated Machine Learning Diagnostic Support System as a Computational Biomarker for Detecting Drug-Induced Liver Injury Patterns in Whole Slide Liver Pathology Images.

Authors:  Munish Puri
Journal:  Assay Drug Dev Technol       Date:  2019-05-31       Impact factor: 1.738

Review 3.  Artificial intelligence and machine learning in precision and genomic medicine.

Authors:  Sameer Quazi
Journal:  Med Oncol       Date:  2022-06-15       Impact factor: 3.738

Review 4.  Artificial intelligence and the hunt for immunological disorders.

Authors:  Nicholas L Rider; Renganathan Srinivasan; Paneez Khoury
Journal:  Curr Opin Allergy Clin Immunol       Date:  2020-12

5.  Precision oncology: lessons learned and challenges for the future.

Authors:  Hsih-Te Yang; Ronak H Shah; David Tegay; Kenan Onel
Journal:  Cancer Manag Res       Date:  2019-08-07       Impact factor: 3.989

6.  FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures.

Authors:  Hyunbin Kim; Andy Jinseok Lee; Jongkeun Lee; Hyonho Chun; Young Seok Ju; Dongwan Hong
Journal:  Genome Med       Date:  2019-12-17       Impact factor: 11.117

Review 7.  Genetic Mosaicism as a Cause of Inborn Errors of Immunity.

Authors:  Jahnavi Aluri; Megan A Cooper
Journal:  J Clin Immunol       Date:  2021-04-16       Impact factor: 8.317

Review 8.  Artificial intelligence for precision medicine in neurodevelopmental disorders.

Authors:  Mohammed Uddin; Yujiang Wang; Marc Woodbury-Smith
Journal:  NPJ Digit Med       Date:  2019-11-21

9.  A pan-cancer landscape of somatic mutations in non-unique regions of the human genome.

Authors:  Peter Van Loo; Tomasz Konopka; Maxime Tarabichi; Jonas Demeulemeester; Annelien Verfaillie; Adrienne M Flanagan
Journal:  Nat Biotechnol       Date:  2021-07-19       Impact factor: 68.164

10.  SomaticCombiner: improving the performance of somatic variant calling based on evaluation tests and a consensus approach.

Authors:  Mingyi Wang; Wen Luo; Kristine Jones; Xiaopeng Bian; Russell Williams; Herbert Higson; Dongjing Wu; Belynda Hicks; Meredith Yeager; Bin Zhu
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.